D-0182-2025 Class II Ongoing
FDA drug recall D-0182-2025 was initiated by FDC Limited on Dec 16, 2024 and is designated Class II. Reason for recall: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle The recall status is ongoing. Affected quantity: 136,181 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 15, 2025
- Initiation Date
- Dec 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 136,181 bottles
Product description
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05
Reason for recall
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Distribution pattern
Nationwide
Code information
Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0182-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026